A record of what Sumeet Bagadia said publicly, with the source. Not advice.
“Recommends buying Dr. Reddy's Laboratories around ₹1200.50, setting a stop-loss at ₹1158 for a target price of ₹1284. The stock shows strong bullish momentum with consistent higher highs and lows, a solid bullish candlestick pattern, and increased trading volumes.”
Sumeet Bagadia’s track record (trackable calls only): 1528 graded calls · 95% CI 32–37%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.
No entry price is stated, so the call starts at the first close after it was published.
Target ₹1,284, stop ₹1,158, as stated.
No time frame is stated, so it is tracked until a close reaches ₹1,284 or ₹1,158: there is no fixed window.
The stop ₹1,158 was reached on a close before the target ₹1,284. Miss.
The grader’s working: R4 TARGET_CALL: entered ₹1198.7 on 2025-04-28 (next trading session's close); stop ₹1158 breached at close ₹1148 on 2025-05-08. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.